Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

E Fernandez-Cruz, B A Woda, J D Feldman, E Fernandez-Cruz, B A Woda, J D Feldman

Abstract

Established subcutaneous Moloney sarcomas (MST-1) of large size and long duration were eliminated from syngeneic rats by intravenous infusion of varying numbers of specific syngeneic effector T lymphocytes. Spleen cells from BN rats in which tumor had regressed were cultured in an in vitro mixed lymphocyte tumor cell culture (MLTC) to augment cytotoxicity of effector cells. In the MLTC a T cell subset was expanded in response to MST-1 antigens and transformed into blast elements. With these changes, there was an increase in the W3/25 antigen on the T cell surface, a decrease of W3/13 antigen, and an increase in the number of T cells with Ia antigens. The subset associated with elimination of established tumors was a blast T cell W3/25+, W3/13+, as detected by monoclonal antibodies to rat T antigens. The W3/25+ subset was poorly cytotoxic in vitro for MST-1 and apparently functioned in vivo as an amplifier or helper cell in the tumor-bearing host. The W3/25- population was a melange of cells that included (W3/13+, W3/25-) T cells, null cells, Ig+ cells, and macrophages, and was associated with enhancement of tumor in vivo, suggesting the presence of suppressor cells.

References

    1. J Natl Cancer Inst. 1970 Apr;44(4):955-63
    1. Cancer Res. 1966 Jul;26(7):1508-15
    1. Surg Forum. 1966;17:102-4
    1. Cancer Res. 1967 Nov;27(11):2207-11
    1. Cancer Res. 1967 Dec;27(12):2521-6
    1. Cancer Res. 1969 Mar;29(3):515-20
    1. Cancer Res. 1969 Apr;29(4):848-54
    1. Cancer Res. 1969 Dec;29(12):2177-83
    1. Int J Cancer. 1971 Jan 15;7(1):160-6
    1. J Natl Cancer Inst. 1970 Aug;45(2):377-86
    1. Int J Cancer. 1971 Nov 15;8(3):364-73
    1. Cancer Res. 1972 May;32(5):997-1001
    1. J Immunol. 1972 May;108(5):1353-61
    1. J Immunol. 1972 Dec;109(6):1371-8
    1. J Natl Cancer Inst. 1973 Jan;50(1):137-47
    1. Cancer Res. 1973 Apr;33(4):641-4
    1. Eur J Immunol. 1973 Apr;3(4):218-24
    1. J Immunol. 1974 Nov;113(5):1417-23
    1. Br J Cancer. 1974 Aug;30(2):118-28
    1. J Immunol. 1975 May;114(5):1491-6
    1. J Natl Cancer Inst. 1975 Mar;54(3):777-80
    1. Int J Cancer. 1974 Nov 15;14(5):662-74
    1. Int J Cancer. 1975 Jun 15;15(6):962-72
    1. Int J Cancer. 1975 Aug 15;16(2):275-83
    1. J Natl Cancer Inst. 1975 Nov;55(5):1227-9
    1. Int J Cancer. 1976 Mar 15;17(3):342-50
    1. J Immunol. 1976 Apr;116(4):976-81
    1. J Immunol. 1976 May;116(5):1367-72
    1. J Immunol. 1976 Jun;116(6):1507-11
    1. Transplantation. 1976 Aug;22(2):184-9
    1. Cancer Res. 1976 Nov;36(11 Pt 1):4039-43
    1. Ann N Y Acad Sci. 1976;277(00):492-504
    1. J Immunol. 1977 Jan;118(1):122-8
    1. J Immunol Methods. 1977;15(1):47-56
    1. J Natl Cancer Inst. 1977 May;58(5):1315-22
    1. J Immunol Methods. 1977;16(1):39-58
    1. Adv Cancer Res. 1977;25:323-88
    1. Ann N Y Acad Sci. 1976;276:165-75
    1. J Exp Med. 1977 Aug 1;146(2):381-93
    1. J Exp Med. 1977 Aug 1;146(2):468-82
    1. Cell. 1977 Nov;12(3):663-73
    1. Int J Cancer. 1978 Feb 15;21(2):230-3
    1. J Exp Med. 1978 Sep 1;148(3):664-73
    1. J Exp Med. 1978 Oct 1;148(4):1093-8
    1. J Immunol. 1978 Dec;121(6):2220-7
    1. J Exp Med. 1978 Nov 1;148(5):1423-8
    1. J Exp Med. 1978 Nov 1;148(5):1440-5
    1. J Exp Med. 1978 Dec 1;148(6):1550-9
    1. J Exp Med. 1979 Feb 1;149(2):416-23
    1. Proc Natl Acad Sci U S A. 1979 Feb;76(2):920-4
    1. J Immunol. 1979 Mar;122(3):1166-71
    1. J Immunol. 1979 Apr;122(4):1510-8
    1. J Exp Med. 1979 Aug 1;150(2):246-55
    1. Nature. 1979 Aug 23;280(5724):685-8
    1. Int J Cancer. 1979 Jul 15;24(1):80-6
    1. J Immunol. 1979 Oct;123(4):1772-7
    1. J Immunol. 1979 Nov;123(5):2161-7
    1. J Exp Med. 1979 Dec 1;150(6):1293-309
    1. J Exp Med. 1979 Dec 1;150(6):1472-82
    1. J Exp Med. 1980 Jan 1;151(1):69-80
    1. J Immunol. 1980 Feb;124(2):846-50
    1. Br J Cancer. 1965 Jun;19:411-7
    1. J Natl Cancer Inst. 1973 Oct;51(4):1317-8
    1. Eur J Immunol. 1973 Aug;3(8):471-6
    1. Int J Cancer. 1972 Nov;10(3):539-47
    1. J Immunol. 1974 Jan;112(1):79-86
    1. J Immunol. 1974 Feb;112(2):533-9
    1. J Natl Cancer Inst. 1974 Jun;52(6):1771-7
    1. J Natl Cancer Inst. 1974 Jun;52(6):1917-8
    1. Cancer Res. 1974 Jul;34(7):1726-30
    1. J Immunol. 1974 Oct;113(4):1302-12

Source: PubMed

3
Se inscrever